OPEN REGISTRY: Assessing Pediatric Endpoints in Myotonic Dystrophy Type 1 (DM1)

The overall goal of the study is to establish valid clinical endpoint assessments for children with congenital myotonic dystrophy type 1 and childhood myotonic dystrophy type 1, and develop biomarkers for the condition.

MORE INFO: ClinicalTrials.gov